Forum for Science, Industry and Business
  • Sponsored by:
  • Siemens
  • Siemens
  • Siemens
Search our Site:

Topic (optional):

 

Home Reports Health and Medicine Content

The growing Staphylococcus aureus arsenal

next article
19.11.2002

 


Staphylococcus aureus is an opportunistic pathogen with a diverse battery of virulence factors, each of which can act alone or in concert in the development of persistent and sometimes lethal infections such as sepsis, toxic shock syndrome, food poisoning and severe skin diseases.


Staphylococcal infections begin when the organism gains access to host tissues or the adjoining blood supply through breaches in the skin. More than 20% of healthy humans are natural carriers of S. aureus, 10%-20% of these carriers harbor multidrug-resistant strains, and the frequencies of both community-acquired and hospital-acquired staphylococcal infections continue to increase. Disturbingly, our stockpile of antibiotics is not evolving at a rate capable of quelling the uprising of resistance.

Determining whether an infection is contained or succeeds in spreading is a complex battle between defensive cells of the patient’s immune system and the onslaught of the array of enzymes, toxins and other injurious factors released by the bacterium. During early stages of infection the S. aureus expresses proteins that enable its binding to, and colonization of, host tissue. Following establishment within the host, other toxins and enzymes help the staphylococci spread to nearby tissue and begin the process of colonization over and over again.

In the November 18 issue of the Journal of Clinical Investigation Eric Brown and colleagues from the Texas A&M University Health Science Center further investigate the role of another interesting member of the S. aureus artillery. The MHC class II Analog Protein (known as Map) was shown to interfere with the function of T cells, a patient’s most specific defense against foreign intruders, which appeared to promote the persistence and survival of S. aureus in infected mice.


CONTACT:
Eric Brown
Texas A&M University System Health Science Center
Albert B. Alkek Institute of Biosciences and Technology
2121 W. Holcombe Blvd.
Suite 603
Houston, TX 77030-7552
USA
Phone 1: 713-677-7572
Fax 1: 713-677-7576
E-mail: ebrown@ibt.tamu.edu

Brooke Grindlinger, PhD | Source: EurekAlert!
Further information: www.the-jci.org/press/16318.pdf

next article

B2B Search

Product / Service
Company / Organisation

Latest News

Scientists find new insight into genome of neglected malaria parasite

10.10.2008 | Life Sciences

Hodgkin lymphoma -- new characteristics discovered

10.10.2008 | Life Sciences

Digital zebrafish embryo provides the first complete developmental blueprint of a vertebrate

10.10.2008 | Life Sciences